KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Revenue (2016 - 2025)

Historic Revenue for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $2.8 billion.

  • Quest Diagnostics' Revenue rose 1318.33% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 billion, marking a year-over-year increase of 1374.36%. This contributed to the annual value of $9.9 billion for FY2024, which is 670.13% up from last year.
  • As of Q3 2025, Quest Diagnostics' Revenue stood at $2.8 billion, which was up 1318.33% from $2.8 billion recorded in Q2 2025.
  • Quest Diagnostics' 5-year Revenue high stood at $2.8 billion for Q3 2025, and its period low was $2.3 billion during Q4 2023.
  • In the last 5 years, Quest Diagnostics' Revenue had a median value of $2.5 billion in 2024 and averaged $2.5 billion.
  • In the last 5 years, Quest Diagnostics' Revenue soared by 4928.65% in 2021 and then tumbled by 1497.81% in 2022.
  • Over the past 5 years, Quest Diagnostics' Revenue (Quarter) stood at $2.7 billion in 2021, then fell by 14.98% to $2.3 billion in 2022, then decreased by 1.93% to $2.3 billion in 2023, then rose by 14.55% to $2.6 billion in 2024, then grew by 7.44% to $2.8 billion in 2025.
  • Its Revenue was $2.8 billion in Q3 2025, compared to $2.8 billion in Q2 2025 and $2.7 billion in Q1 2025.